Upstream regulatory mutations in BRCA1 and PALB2 may further influence miR-184’s apoptotic effects in breast and pancreatic cancers [66], illustrating how its function depends on the dominance of specific pathways or ceRNA dynamics within a given tumour context. The gene discussed is PALB2; the disease is pancreatic neoplasm.